News Headlines Article

New melanoma drug may shrink brain tumors
Yahoo! News

An experimental melanoma drug from GlaxoSmithKline managed to shrink secondary tumors in the brains of nine patients with advanced disease, according to results of a small clinical trial on Sunday. The development is encouraging because secondary tumors, or metastases, in the brain are a major problem in the deadly form of skin cancer.